Premium
Biocon Ltd is considering a plan to sell its generic active pharmaceutical ingredient (API) business to lower its debt, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.